{"quote": {"result": [{"language": "en-US", "region": "US", "quoteType": "EQUITY", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": false, "customPriceAlertConfidence": "LOW", "currency": "EUR", "exchange": "FRA", "shortName": "PHERECYDES PHARMA  EO 1", "longName": "Pherecydes Pharma Soci\u00e9t\u00e9 anonyme", "messageBoardId": "finmb_252792572", "exchangeTimezoneName": "Europe/Berlin", "exchangeTimezoneShortName": "CEST", "gmtOffSetMilliseconds": 7200000, "market": "dr_market", "esgPopulated": false, "regularMarketChangePercent": -4.5871625, "regularMarketPrice": 2.08, "marketState": "REGULAR", "fiftyTwoWeekHighChangePercent": -0.5706914, "fiftyTwoWeekLow": 1.836, "fiftyTwoWeekHigh": 4.845, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "epsTrailingTwelveMonths": -0.81, "sharesOutstanding": 7199420, "bookValue": 1.411, "fiftyDayAverage": 2.4667, "fiftyDayAverageChange": -0.38670015, "fiftyDayAverageChangePercent": -0.1567682, "twoHundredDayAverage": 2.39965, "twoHundredDayAverageChange": -0.31965017, "twoHundredDayAverageChangePercent": -0.133207, "marketCap": 15101694, "priceToBook": 1.4741317, "sourceInterval": 15, "exchangeDataDelayedBy": 15, "prevName": "Pherecydes Pharma SA", "nameChangeDate": "2023-05-11", "tradeable": false, "cryptoTradeable": false, "priceHint": 4, "regularMarketChange": -0.10000014, "regularMarketTime": 1683892037, "regularMarketDayHigh": 2.08, "regularMarketDayRange": "2.02 - 2.08", "regularMarketDayLow": 2.02, "regularMarketVolume": 200, "regularMarketPreviousClose": 2.18, "bid": 0.0, "ask": 0.0, "fullExchangeName": "Frankfurt", "financialCurrency": "EUR", "regularMarketOpen": 2.02, "averageDailyVolume3Month": 11, "averageDailyVolume10Day": 0, "fiftyTwoWeekLowChange": 0.24399996, "fiftyTwoWeekLowChangePercent": 0.13289759, "fiftyTwoWeekRange": "1.836 - 4.845", "fiftyTwoWeekHighChange": -2.7649999, "firstTradeDateMilliseconds": 1613458800000, "symbol": "35L.F"}], "error": null}, "summary": {"result": [{"assetProfile": {"address1": "102 avenue Gaston Roussel", "city": "Romainville", "zip": "93230", "country": "France", "phone": "33 1 48 40 65 35", "website": "https://www.pherecydes-pharma.com", "industry": "Biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "longBusinessSummary": "Pherecydes Pharma Soci\u00e9t\u00e9 anonyme develops antibacterial treatments based on the use of bacteriophage viruses or phages. It develops a portfolio of therapeutics, such as anti-staphylococcus aureus for the treatment of bone/joint and diabetic foot ulcer infections; anti-pseudomonas aeruginosa, a phage therapy treatment for respiratory tract infections; and anti-escherichia coli for the treatment of respiratory tract infections. The company was founded in 2006 and is headquartered in Romainville, France.", "fullTimeEmployees": 27, "companyOfficers": [{"maxAge": 1, "name": "Mr. Thibaut du Fayet", "age": 54, "title": "Chief Exec. Officer", "yearBorn": 1968, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Pascal  Birman", "title": "C.M.O", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}], "maxAge": 86400}}], "error": null}}